Dr. Reddiah Babu Mummaneni, MD

Dr. Mummaneni practices at Seton Family of Doctors in Austin, Texas.

Dr. Mummaneni's NPI, 1568516987, was assigned on January 23, 2007. Dr. Mummaneni graduated from Siddhartha Medical College NTR in 1997. Dr. Mummaneni holds Texas license P4210.

Dr. Mummaneni's primary practice is Seton Family of Doctors, at 4616 W Howard Ln, Austin, TX 78728 in Travis County. The practice phone is (512) 324-8300.

Dr. Mummaneni's primary practice is Seton Family of Doctors in Austin, Texas. Dr. Mummaneni is also affiliated with Ascension Seton Cedar Park Hospital. The medical group on file is Seton Family of Doctors. Dmand AI also links Dr. Mummaneni to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mummaneni practices. Vendor and product names are available with a free account.

Neurology is Dr. Mummaneni's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mummaneni is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Mummaneni's licenses on file in 4 states: Texas, South Carolina, Georgia and Illinois.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Mummaneni treats.

CMS data shows 832 Medicare services from Dr. Mummaneni across 9 procedure codes in 2024, for 566 Medicare patients. Medicare paid $73,185 for them.

CMS counts 566 Medicare patients who saw Dr. Mummaneni in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mummaneni's median patient age at 66, with 52% women.

In 2024, Dr. Mummaneni wrote 2,211 Medicare Part D claims for 409 patients. 89% of them were for generic drugs. CMS names the drug for 1,984 of them, across 48 drugs with 11 or more claims each, at $242,759 in total drug cost. In 2023, CMS named 1,990 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Mummaneni for performance year 2024, reported through an alternative payment model (APM). Dr. Mummaneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mummaneni as offering telehealth.

Dmand AI links 1 paper to Dr. Mummaneni in 2011. Dr. Mummaneni's most frequent co-authors are Mazen M. Dimachkie, MD, April L. McVey, MD and Manoj K. Mittal, MD.

CMS Open Payments shows 1,190 general payments to Dr. Mummaneni from 67 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,855.

Dr. Mummaneni graduated from Siddhartha Medical College NTR in 1997.

Dr. Mummaneni is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.